• Contracted and External Reports

These reports were prepared by independent contractors, and the Office of the Superintendent of Insurance provides them for informational purposes only. The findings, conclusions, and recommendations expressed herein are those of the contractors and do not necessarily reflect the views, policies, or positions of the Office of Superintendent of Insurance. The agency does not endorse or guarantee the accuracy or completeness of the information presented.

Impact of Federal and State Premiums Subsidies on New Mexico Households: Consumers’ Checkbook/Center for the Study of Services, Oct 2025

Using Insurance Coverage to Improve Health Equity in New Mexico: Recommendations for the Office of the Superintendent of Insurance, Princeton School of Public and International Affairs, Policy Workshop Report, Dec 2023

Global Budgeting Study: Health Management Associates, 6 reports, May – Sept 2023

Medicaid Forward in New Mexico: Health Coverage, Health Care Spending, and Government Costs: Research Report, The Urban Institute, Aug 2023

Payment Models for New Mexico: Miriam Laugesen and Michael Gusmano, March 2022

An Analysis of NM Health Security Act: Sara Rosenbaum, et al, Jan 2022

Hospital Global Budgets: Landon and Associates, Jan 2022

NM Hospital Global Budgets Report: Bailit Health Purchasing, Jan 2022

Recent News

Get the latest information about rule changes, legislation, industry information and consumer news.

Read All OSI News

MEDICAL MALPRACTICE PREMIUM REDUCTION

AMENDED BULLETIN 2026-010: The New Mexico State Legislature appropriated $5 million to the New Mexico Office of Superintendent of Insurance (OSI) to address medical malpractice insurance costs for individual providers. The appropriation was part of a supplemental appropriation package passed in 2025. This one-time appropriation directs OSI to provide a premium subsidy for private medical malpractice insurance policies. […]

Read More

NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING

The Office of the Superintendent of Insurance will hold its annual public meeting to present and discuss the findings and recommendations contained in the 2025 Prescription Drug Price Transparency legislative report. The purpose of this meeting is to inform the public of the report’s contents and to provide an opportunity for public comments and questions. […]

Read More